International Journal of Hematology
Overview
The International Journal of Hematology is a peer-reviewed medical journal that focuses on the study and treatment of blood disorders. It publishes original research articles, reviews, and case reports covering various aspects of hematology, including hematopoiesis, hematological malignancies, transfusion medicine, and stem cell transplantation. The journal serves as a valuable resource for hematologists, oncologists, and researchers in the field, providing up-to-date information on advancements in hematology and contributing to the improvement of patient care.
Details
Details
Abbr.
Int J Hematol
Start
1991
End
Continuing
Frequency
Monthly, 2011-
p-ISSN
0925-5710
e-ISSN
1865-3774
Country
Japan
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 3937
86
SJR / Ranks: 7585
594
CiteScore / Ranks: 7225
3.70
JIF / Ranks: 5004
2.1
Recent Articles
1.
Yoshikawa T, Ishida H, Watanabe A, Yuza Y, Shima H, Ito M, et al.
Int J Hematol
. 2025 Mar;
PMID: 40088374
Chronic myeloid leukemia (CML) is a rare disease during childhood, and accelerated phase (AP) and blast phase (BP) CML, also called advanced phases, are even rarer. We retrospectively collected and...
2.
Imashuku S, Kazuma Y, Chonabayashi K, Shimazu Y, Kanda J, Nannya Y, et al.
Int J Hematol
. 2025 Mar;
PMID: 40085347
We report here a case of myelodysplastic syndrome (MDS) that developed in a 60-year-old female with dehydrated hereditary stomatocytosis 1 (DHS1) with PIEZO1 gene mutation (p. E2496ELE). The patient had...
3.
Goto T, Okamura H, Ikeda T, Mori Y, Shiratori S, Fujiwara S, et al.
Int J Hematol
. 2025 Mar;
PMID: 40072824
In the randomized, double-blind, phase 3 GRAPHITE study (NCT03657160), anti-αβ integrin antibody vedolizumab showed greater efficacy than placebo for prevention of lower-gastrointestinal (GI) acute graft-versus-host disease (aGVHD) after unrelated allogenic...
4.
Kamiunten A, Kameda T, Sekine M, Kawano H, Toyama T, Akizuki K, et al.
Int J Hematol
. 2025 Mar;
PMID: 40067419
Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy with a poor prognosis. We conducted a retrospective study across six institutions in Miyazaki Prefecture, Japan, to assess the efficacy of...
5.
Asano T, Morimoto A, Nakazawa A, Ueda T, Ogawa C, Sakata N, et al.
Int J Hematol
. 2025 Mar;
PMID: 40063331
Background: Rosai-Dorfman-Destombes disease (RDD) is a rare form of histiocytosis, characterized by the accumulation of S100 protein-positive and CD1a-negative histiocytes with emperipolesis. Recently, oncogenic mutations in mitogen-activated protein kinase pathway...
6.
Shimomura M, Ashiarai M, Kato I, Kamiya T, Taketomi N, Akita T, et al.
Int J Hematol
. 2025 Mar;
PMID: 40063330
We retrospectively analyzed the effect of conditioning intensity on 22 late complications in 145 adolescent and young adults who underwent allogeneic hematopoietic cell transplantation (HCT) in childhood. Seventy-six patients received...
7.
Sato S, Sawazaki E, Tsunoda S, Kamata W, Togano T, Tamai Y
Int J Hematol
. 2025 Mar;
PMID: 40057936
Background: The prognostic significance of minimal residual disease (MRD) negativity in multiple myeloma (MM) is well-established, and MRD negativity serves as a surrogate marker for treatment outcomes. However, in various...
8.
Abreu Lopez B, Arvelaez Pascucci J, Ramzy S, Mehta S, Daniel S, Dave R, et al.
Int J Hematol
. 2025 Mar;
PMID: 40057935
Background: Essential thrombocythemia (ET) is a myeloproliferative neoplasm commonly treated with hydroxyurea, while anagrelide is a second-line option. Although anagrelide has thrombocyte-specific action, its comparative efficacy remains debated. This systematic...
9.
10.